U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C48H66N5O10.ClH
Molecular Weight 909.526
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Motexafin hydrochloride

SMILES

Cl.CCc1c(CC)c2cc3nc(cnc4cc(OCCOCCOCCOC)c(OCCOCCOCCOC)cc4ncc5nc(cc1n2)c(CCCO)c5C)c(C)c3CCCO

InChI

InChIKey=YTGKTHDEEFVADV-CWLLKONLSA-N
InChI=1S/C48H67N5O10.ClH/c1-7-35-36(8-2)40-28-42-38(12-10-14-55)34(4)46(53-42)32-50-44-30-48(63-26-24-61-22-20-59-18-16-57-6)47(62-25-23-60-21-19-58-17-15-56-5)29-43(44)49-31-45-33(3)37(11-9-13-54)41(52-45)27-39(35)51-40;/h27-32,51,54-55H,7-26H2,1-6H3;1H/b39-27-,40-28-,41-27-,42-28-,45-31-,46-32-,49-31+,49-43+,50-32+,50-44+;

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C48H66N5O10
Molecular Weight 873.0651
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Motexafin is texaphyrin patented by pharmaceutical company Pharmacyclics, Inc. as chelating agents useful for the treatment of neoplastic and cardiovascular disease. The MRI-detectable gadolinium complex of motexafin was studied as a redox modulator that selectively targets tumor cells.

Approval Year

PubMed

PubMed

TitleDatePubMed
Motexafin gadolinium: a novel radiosensitizer for brain tumors.
2007-06
Motexafin gadolinium in the treatment of brain metastases.
2007-02
Patents

Patents

Substance Class Chemical
Created
by admin
on Wed Apr 02 06:42:21 GMT 2025
Edited
by admin
on Wed Apr 02 06:42:21 GMT 2025
Record UNII
X4BY26ZT9J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Motexafin hydrochloride
Systematic Name English
8,11-Imino-3,6:16,13-dinitrilo-1,18-benzodiazacycloeicosine-5,14-dipropanol, 9,10-diethyl-20,21-bis[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]-4,15-dimethyl-, hydrochloride
Preferred Name English
Code System Code Type Description
CAS
917562-97-1
Created by admin on Wed Apr 02 06:42:21 GMT 2025 , Edited by admin on Wed Apr 02 06:42:21 GMT 2025
PRIMARY
FDA UNII
X4BY26ZT9J
Created by admin on Wed Apr 02 06:42:21 GMT 2025 , Edited by admin on Wed Apr 02 06:42:21 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY